Proteinase‐activated receptor 1: A target for repurposing in the treatment of COVID‐19?
出版年份 2020 全文链接
标题
Proteinase‐activated receptor 1: A target for repurposing in the treatment of COVID‐19?
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-07-08
DOI
10.1111/bph.15194
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A hypothesis for pathobiology and treatment of COVID‐19 : The centrality of ACE1 / ACE2 imbalance
- (2020) Krishna Sriram et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
- (2020) Thomas J. Oxley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
- (2020) Cynthia Magro et al. Translational Research
- COVID-19 cytokine storm: the interplay between inflammation and coagulation
- (2020) Ricardo J Jose et al. Lancet Respiratory Medicine
- Active thrombin produced by the intestinal epithelium controls mucosal biofilms
- (2019) Jean-Paul Motta et al. Nature Communications
- THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
- (2019) Stephen P H Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases
- (2018) Jens J. Posma et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia
- (2016) Yan Yang et al. Cellular & Molecular Immunology
- Immunothrombosis in Acute Respiratory Distress Syndrome: Cross Talks between Inflammation and Coagulation
- (2016) Frantzeska Frantzeskaki et al. RESPIRATION
- Thrombin Increases Lung Fibroblast Survival while Promoting Alveolar Epithelial Cell Apoptosis via the Endoplasmic Reticulum Stress Marker, CCAAT Enhancer–Binding Homologous Protein
- (2013) Ilia Atanelishvili et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Thrombin induces epithelial-mesenchymal transition via PAR-1, PKC, and ERK1/2 pathways in A549 cells
- (2013) Jeong Sup Song et al. EXPERIMENTAL LUNG RESEARCH
- PAR-1 contributes to the innate immune response during viral infection
- (2013) Silvio Antoniak et al. JOURNAL OF CLINICAL INVESTIGATION
- Modulation of Protease Activated Receptor 1 Influences Human Metapneumovirus Disease Severity in a Mouse Model
- (2013) Laetitia Aerts et al. PLoS One
- Proteinase-activated receptors in fibroproliferative lung disease
- (2013) Ricardo J José et al. THORAX
- Pharmacokinetics of the novel PAR-1 antagonist vorapaxar in patients with hepatic impairment
- (2012) Paul Statkevich et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- PAR1 contributes to influenza A virus pathogenicity in mice
- (2012) Khaled Khoufache et al. JOURNAL OF CLINICAL INVESTIGATION
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events
- (2012) David A. Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Concentration dependent dual effect of thrombin in endothelial cells via Par-1 and Pi3 Kinase
- (2009) Jong-Sup Bae et al. JOURNAL OF CELLULAR PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search